Category:Gregory Hinkle of Plymouth MA (US)
Gregory Hinkle of Plymouth MA (US)
Executive Summary
Gregory Hinkle of Plymouth MA (US) is an inventor who has filed 4 patents. Their primary areas of innovation include Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants (4 patents), MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media (3 patents), PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms (2 patents), and they have worked with companies such as Alnylam Pharmaceuticals, Inc. (4 patents). Their most frequent collaborators include (3 collaborations), (2 collaborations), (2 collaborations).
Patent Filing Activity
File:Gregory Hinkle of Plymouth MA (US) Monthly Patent Applications.png
_Monthly_Patent_Applications.png){kind=link}
Technology Areas
File:Gregory Hinkle of Plymouth MA (US) Top Technology Areas.png
_Top_Technology_Areas.png){kind=link}
List of Technology Areas
- C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants): 4 patents
- C12N2310/14 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 patents
- A61K31/713 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 2 patents
- A61K47/549 ({Sugars, nucleosides, nucleotides or nucleic acids}): 2 patents
- C12N2310/315 (of the backbone): 2 patents
- C12N2310/351 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents
- C12N2310/3515 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents
- C12N2310/343 (Spatial arrangement of the modifications): 2 patents
- C12N2310/321 (2'-O-R Modification): 2 patents
- A61K47/554 ({the modifying agent being a steroid plant sterol, glycyrrhetic acid, enoxolone or bile acid}): 1 patents
- C12N2310/318 (where the PO2 is completely replaced, e.g. MMI or formacetal): 1 patents
- C12N2310/346 (Spatial arrangement of the modifications): 1 patents
- A61K45/06 (Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca): 1 patents
- C12N2320/32 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
- C12N2320/51 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
- A61K31/7105 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
- C12N2310/11 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
- C12N2310/3125 (of the backbone): 1 patents
- C12N2310/313 (of the backbone): 1 patents
- C12N2310/3231 (modified ring structure): 1 patents
- C12N2310/3521 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
- C12N2310/3523 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
- C12N2310/3525 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
- C12Y101/01027 (ENZYMES): 1 patents
- A61P1/16 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
- A61P1/18 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
- A61P3/04 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
- A61P3/06 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
- A61P3/10 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
- A61P9/10 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
- A61P9/12 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
- A61P13/12 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
- A61P15/08 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
- A61P43/00 (Drugs for specific purposes, not provided for in groups): 1 patents
- C12N2310/322 (2'-R Modification): 1 patents
- C12N2310/335 (of the base): 1 patents
Companies
File:Gregory Hinkle of Plymouth MA (US) Top Companies.png
_Top_Companies.png){kind=link}
List of Companies
- Alnylam Pharmaceuticals, Inc.: 4 patents
Collaborators
- Kevin Fitzgerald of Brookline MA (US) (3 collaborations)
- Satyanarayana Kuchimanchi of Acton MA (US) (2 collaborations)
- Martin A. Maier of Belmont MA (US) (2 collaborations)
- Stuart Milstein of Arlington MA (US) (2 collaborations)
- Abigail Liebow of Somerville MA (US) (2 collaborations)
- Huilei Xu of Boston MA (US) (1 collaborations)
- Donald Foster of Attleboro MA (US) (1 collaborations)
- Brian Bettencourt of Groton MA (US) (1 collaborations)
- Klaus Charisse of Acton MA (US) (1 collaborations)
- David Erbe of Arlington MA (US) (1 collaborations)
- Kyle David Wood of Homewood AL (US) (1 collaborations)
- Ross Philip Holmes of Birmingham AL (US) (1 collaborations)
- John Knight of Homewood AL (US) (1 collaborations)
- William Querbes of Boston MA (US) (1 collaborations)
- James Butler of Lynnfield MA (US) (1 collaborations)
- Stephanie Williams of Littleton MA (US) (1 collaborations)
- Muthiah Manoharan of Weston MA (US) (1 collaborations)
Subcategories
This category has the following 11 subcategories, out of 11 total.
A
B
D
G
K
M
S
W
Categories:
- Kevin Fitzgerald of Brookline MA (US)
- Satyanarayana Kuchimanchi of Acton MA (US)
- Martin A. Maier of Belmont MA (US)
- Pages with broken file links
- Stuart Milstein of Arlington MA (US)
- Abigail Liebow of Somerville MA (US)
- Huilei Xu of Boston MA (US)
- Donald Foster of Attleboro MA (US)
- Brian Bettencourt of Groton MA (US)
- Klaus Charisse of Acton MA (US)
- David Erbe of Arlington MA (US)
- Kyle David Wood of Homewood AL (US)
- Ross Philip Holmes of Birmingham AL (US)
- John Knight of Homewood AL (US)
- William Querbes of Boston MA (US)
- James Butler of Lynnfield MA (US)
- Stephanie Williams of Littleton MA (US)
- Muthiah Manoharan of Weston MA (US)
- Gregory Hinkle of Plymouth MA (US)
- Inventors
- Inventors filing patents with Alnylam Pharmaceuticals, Inc.